Clinical trial
Non-Invasive Preeclampsia Screening and Biobank
NCT06643741
Study timeline
Study start (actual)2025-02-02Date precision: day
Registry last updated2026-07-20
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Preeclampsia (PE)unresolved
Interventions
Sponsors & collaborators
Sequenom, Inc.lead sponsor
Rutgers Robert Wood Johnson Medical Schoolcollaborator
Laboratory Corporation of Americacollaborator
Mapped research locations
New YorkNew York, United States2HoustonTexas, United States2PhiladelphiaPennsylvania, United States2BostonMassachusetts, United States1MiamiFlorida, United States1AustinTexas, United States1Winston-SalemNorth Carolina, United States1NorfolkVirginia, United States1New BrunswickNew Jersey, United States1ChattanoogaTennessee, United States1NewarkDelaware, United States1GalvestonTexas, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06643741 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.